Association of acute kidney injury and chronic kidney disease with processes of care and long-term outcomes in patients with acute myocardial infarction.


Journal Article

Aims: To examine the association of acute kidney injury (AKI) with long-term outcomes after myocardial infarction (MI), and evaluate whether effect modification is present according to baseline chronic kidney disease (CKD) status. Methods and results: ACTION Registry records from 2008 to 2012 were linked to Medicare claims data, creating a cohort of 76 500 acute MI patients aged ≥ 65 years who survived to hospital discharge. Mild, moderate, and severe AKI were defined as changes in creatinine from baseline to peak of 0.3 to < 0.5, 0.5 to < 1.0, and ≥ 1.0 mg/dL, respectively. Stage 3, Stage 4, and Stage 5 CKD were defined as estimated glomerular filtration rates of 30-59, 15-29, and <15 mL/min/m2, respectively. Cox proportional hazards modelling was used to examine associations of AKI with long-term outcomes. The prevalence of baseline CKD was: Stage 3 (41.2%), Stage 4 (6.7%), and Stage 5 (1.0%). The incidence of AKI was: mild (7.5%), moderate (6.0%), and severe (3.0%). A significant interaction of AKI with baseline CKD was observed for 1-year mortality (Pinteraction <0.001). Acute kidney injury was associated with worse multivariable-adjusted 1-year mortality among individuals without CKD: mild AKI [hazard ratio (HR): 1.33, 95% confidence interval (CI): 1.22-1.49], moderate AKI (HR:1.66, 95% CI: 1.46-1.89), and severe AKI (HR: 2.87, 95% CI: 2.41-3.43). An attenuation of this effect was noted with advancing stages of baseline CKD such that among patients with Stage 5 CKD, AKI was not associated with 1-year mortality. Conclusion: Acute kidney injury is associated with worse long-term outcomes after MI. This effect is modified by baseline CKD status.

Full Text

Duke Authors

Cited Authors

  • Mody, P; Wang, T; McNamara, R; Das, S; Li, S; Chiswell, K; Tsai, T; Kumbhani, D; Wiviott, S; Goyal, A; Roe, M; de Lemos, JA

Published Date

  • January 1, 2018

Published In

Volume / Issue

  • 4 / 1

Start / End Page

  • 43 - 50

PubMed ID

  • 29293980

Pubmed Central ID

  • 29293980

Electronic International Standard Serial Number (EISSN)

  • 2058-1742

Digital Object Identifier (DOI)

  • 10.1093/ehjqcco/qcx020


  • eng

Conference Location

  • England